您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > LG-120907
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
LG-120907
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CAS NO:201654-12-8
包装:50mg, 100mg, 250mg
规格:≥98%

产品介绍

LG-120907 is a nonsteroidal antiandrogen (NSAA) of the quinoline group which was developed by Ligand Pharmaceuticals along with selective androgen receptor modulators (SARMs) like LG-121071 and was never marketed. The drug is a high-affinity antagonist of the androgen receptor (AR) with a Ki of 26 nM and has been found to inhibit growth of the ventral prostate and seminal vesicles in male rats interestingly without increasing circulating levels of luteinizing hormone or testosterone. However, this tissue selectivity has not been assessed in humans. LG-120907 is orally bioavailable and shows greater orally bioavailable potency than the arylpropionamide NSAA flutamide. References:

纯度:≥98%

CAS:201654-12-8